期刊
JOURNAL OF PSYCHOPHARMACOLOGY
卷 31, 期 5, 页码 519-552出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/0269881117699361
关键词
Antidepressants; antipsychotics; anxiolytics; birth defects; breastfeeding; child development; conception; fertility; hypnotics; mood stabilisers; neonatal problems; postpartum; pregnancy; pregnancy outcome; psychiatric illness; psychotropics; teratogenicity
资金
- Medical Research Council [MR/L010305/1, MR/N029488/1, G108/603] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0616-10074] Funding Source: researchfish
- MRC [G108/603, MR/N029488/1] Funding Source: UKRI
Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge for clinicians and women with mental health problems, owing to the uncertainties around risks of the illness itself to mother and fetus/infant, effectiveness of medications in pregnancy and risks to the fetus/infant from in utero exposure or via breast milk. These consensus guidelines aim to provide pragmatic advice regarding these issues. They are divided into sections on risks of untreated illness in pregnancy; general principles of using drugs in the perinatal period; benefits and harms associated with individual drugs; and recommendations for the management of specific disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据